Key result
P2Y12 inhibitor monotherapy is being evaluated as a potential paradigm shift to replace aspirin monotherapy in patients with coronary artery disease.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Keywords: Aspirin, P2Y12 inhibitor, coronary artery disease, PCI, DAPT, monotherapy.
No takes yet. Share an insight, caveat, or question.
Gragnano et al. (2023) studied this question. P2Y12 inhibitor monotherapy is being evaluated as a potential paradigm shift to replace aspirin monotherapy in patients with coronary artery disease.
Synapse has enriched 10 related papers. Consider them for comparative context: